Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ocular Hypertension (OH)”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Large-scale testing (Phase 3)Study completedNCT00892762
What this trial is testing

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Alcon Research 434
Testing effectiveness (Phase 2)Study completedNCT00967811
What this trial is testing

Different Formulations of the L-PPDS in Subjects With OH or OAG

Who this might be right for
GlaucomaOcular Hypertension
Mati Therapeutics Inc. 83
Large-scale testing (Phase 3)Ended earlyNCT00767494
What this trial is testing

Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT

Who this might be right for
GlaucomaOcular Hypertension
Alcon Research 17
Not applicableLooking for participantsNCT07400926
What this trial is testing

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Who this might be right for
Open Angle Glaucoma (OAG)Ocular Hypertension (OH)
Glaukos Corporation 30
Large-scale testing (Phase 3)Study completedNCT00047593
What this trial is testing

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research
Post-approval studies (Phase 4)Study completedNCT00143208
What this trial is testing

Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 250
Testing effectiveness (Phase 2)Study completedNCT01481077
What this trial is testing

A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension (OH)
Mati Therapeutics Inc. 77
Testing effectiveness (Phase 2)Study completedNCT01229982
What this trial is testing

A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Ocular HypertensionOpen Angle Glaucoma
Mati Therapeutics Inc. 121
Not applicableStudy completedNCT06689696
What this trial is testing

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

Who this might be right for
GlaucomaGLAUCOMA 1, OPEN ANGLE, D (Disorder)Ocular Hypertension+8 more
Smartlens, Inc. 86
Large-scale testing (Phase 3)WithdrawnNCT01721707
What this trial is testing

Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Adapt Produtos Oftalmológicos Ltda.
Post-approval studies (Phase 4)Study completedNCT00647101
What this trial is testing

Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600
Large-scale testing (Phase 3)Study completedNCT01357616
What this trial is testing

Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 328
Large-scale testing (Phase 3)Ended earlyNCT00912054
What this trial is testing

DuoTrav APS Versus XALACOM® in Ocular Surface Health

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Alcon Research 240
Testing effectiveness (Phase 2)Study completedNCT00821002
What this trial is testing

Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Mati Therapeutics Inc. 32
Post-approval studies (Phase 4)Study completedNCT01594970
What this trial is testing

A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Allergan 800
Post-approval studies (Phase 4)Ended earlyNCT00047606
What this trial is testing

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Alcon Research 84
Large-scale testing (Phase 3)Study completedNCT00383019
What this trial is testing

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 300
Testing effectiveness (Phase 2)Study completedNCT01481051
What this trial is testing

A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
GlaucomaOcular Hypertension (OH)
Mati Therapeutics Inc. 57
Not applicableUnknownNCT01084902
What this trial is testing

Efficacy Comparison of Xalatan and Azopt on POAG and OH

Who this might be right for
Ocular Hypertension
Peking University First Hospital 130
Large-scale testing (Phase 3)Study completedNCT00546286
What this trial is testing

Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

Who this might be right for
GlaucomaOcular Hypertension
Merck Sharp & Dohme LLC 170
Load More Results